Relating to participation in federal prescription drug pricing programs.

Summary

The bill lets the Public Employees Insurance Agency and the Department of Human Services voluntarily opt into federal prescription‑drug pricing initiatives, such as most‑favored‑nation or reference‑price models. Participation must be deemed financially beneficial and must not limit beneficiaries’ access to needed medicines. The agencies must report yearly savings and any issues to the Joint Committee on Government and Finance.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share